VolitionRX Ltd(VNRX) Finding the best opportunities to buy and sell stocks daily.




VolitionRX Ltd. is a multi-national life sciences company, which engages in the development of blood-based cancer tests to help diagnose a range of cancers. The company is headquartered in Austin, Texas and currently employs 44 full-time employees. The firm is focused on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. The firm has developed approximately 30 blood-based assays to detect specific biomarkers that can be used individually or in combination to generate a profile, which forms the basis of a test for a particular cancer or disease. The firm's Nucleosomics biomarker platform is a technology that is used for a range of cancers. The firm is developing Nucleosomics tests for various cancers, including colorectal, pancreatic, lung and aggressive prostate. The firm's NuQ blood assays fall into over five types, which include NuQ-X, NuQ-V, NuQ-M, NuQ-A and NuQ-T. The company has developed approximately two blood assays in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides.

Current Price






August 13, 2020

4128.519 %
-21.311 %
-0.920 %

100.000 %
0.000 %

11.861 %
-17.988 %
-19.391 %
-19.911 %
-13.858 %


Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.